CTGov Compliance My Organizations

Compliance Rate

Compliance Rate 47.32%

Compliant submissions 53

Incompliant submissions 59

Total trials 112

My Organizations' Clinical Trials

Showing 300 of 1129 entries

View as:

Effects of Worksite Wellness Interventions on Vascular Function, Insulin Sensitivity and High-Density Lipoprotein in Overweight or Obese Women

Phase: N/A Priority: Normal

NCT ID: NCT00666172 Org: User:

Start: 04/08/08 End: 11/01/12 Due: 11/01/13

Vascular Effects of Endothelium-Derived Versus Hemoglobin-Transported Nitric Oxide in Healthy Subjects

Phase: N/A Priority: Normal

NCT ID: NCT00001963 Org: User:

Start: 12/31/99 End: 10/31/00 Due: 10/31/01

Framingham Nutrition Studies

Phase: N/A Priority: Normal

NCT ID: NCT00005513 Org: User:

Start: 09/30/98 End: 07/31/02 Due: 07/31/03

Atherosclerosis and Omega-3 Fatty Acids in Alaskan Natives

Phase: N/A Priority: Normal

NCT ID: NCT00005236 Org: User:

Start: 12/31/88 End: 11/30/94 Due: 11/30/95

Biomarkers for Cardiovascular Disease

Phase: N/A Priority: Normal

NCT ID: NCT00109018 Org: User:

Start: 04/19/05 End: 04/15/09 Due: 04/15/10

Aplastic Anemia Epidemiology: Incidence and Case-control

Phase: N/A Priority: Normal

NCT ID: NCT00005682 Org: User:

Start: 09/30/88 End: 08/31/94 Due: 08/31/95

Coronary Heart Disease Incidence, Mortality, and Risk Factor Relationships

Phase: N/A Priority: Normal

NCT ID: NCT00005148 Org: User:

Start: 09/30/79 End: 08/31/91 Due: 08/31/92

Blood Pressure Tracking--Childhood to Young Adulthood

Phase: N/A Priority: Normal

NCT ID: NCT00005421 Org: User:

Start: 09/30/92 End: 03/31/95 Due: 03/31/96

Hemoglobin and Iron Recovery Study

Phase: N/A Priority: Normal

NCT ID: NCT01555060 Org: User:

Start: 03/31/12 End: 06/30/13 Due: 06/30/14

Rituxan/BEAM vs Bexxar/BEAM in Autologous Hematopoietic Stem Cell Transplant for Non-Hodgkin's Lymphoma (BMTCTN0401)

Phase: N/A Priority: Normal

NCT ID: NCT00329030 Org: User:

Start: 12/31/05 End: 08/31/13 Due: 08/31/14

Pilot Study of Strength Testing in Overweight Women With or Without Insulin Resistance

Phase: N/A Priority: Normal

NCT ID: NCT01862757 Org: User:

Start: 05/06/13 End: 03/13/15 Due: 03/13/16

Neighborhood Environments and Cardiovascular Disease

Phase: N/A Priority: Normal

NCT ID: NCT00005505 Org: User:

Start: 12/31/97 End: 11/30/02 Due: 11/30/03

Genetic Basis of Immunodeficiency

Phase: N/A Priority: Normal

NCT ID: NCT00055172 Org: User:

Start: 04/05/04 End: - Due: -

Magnetic Resonance Imaging to Detect Blood Vessel Inflammation in Patients Undergoing Peripheral Balloon Angioplasty

Phase: N/A Priority: Normal

NCT ID: NCT00004549 Org: User:

Start: 01/31/00 End: 01/31/02 Due: 01/31/03

Effects of Rosuvastatin on the Immune System in Healthy Volunteers With Normal Cholesterol

Phase: N/A Priority: Normal

NCT ID: NCT01200836 Org: User:

Start: 07/01/10 End: 10/04/18 Due: 10/04/19

Phosphodiesterase Type-5 Inhibitor Therapy in Sickle Cell People With Pulmonary Hypertension

Phase: N/A Priority: Normal

NCT ID: NCT03572036 Org: User:

Start: 06/20/18 End: 04/16/21 Due: 04/16/22

Weight Set-Point and HDL Concentration in Runners

Phase: N/A Priority: Normal

NCT ID: NCT00005342 Org: User:

Start: 05/31/93 End: 04/30/97 Due: 04/30/98

Complement Inhibition Using Eculizumab to Overcome Platelet Transfusion Refractoriness in Patients With Severe Thrombocytopenia

Phase: N/A Priority: Normal

NCT ID: NCT02298933 Org: User:

Start: 11/21/14 End: 08/08/17 Due: 08/08/18

Specimen Collection for Individuals With Lung Disease Associated With Rheumatoid Arthritis

Phase: N/A Priority: Normal

NCT ID: NCT00001884 Org: User:

Start: 03/21/99 End: 12/28/07 Due: 12/28/08

Lay-Led Smoking Cessation Approach for Southeast Asian Men

Phase: N/A Priority: Normal

NCT ID: NCT00005720 Org: User:

Start: 09/30/90 End: 08/31/96 Due: 08/31/97

Treatment With Octreotide in Patients With Lymphangioleiomyomatosis

Phase: N/A Priority: Normal

NCT ID: NCT00005906 Org: User:

Start: 06/30/00 End: - Due: -

Development and Evaluation of Community Asthma Program

Phase: N/A Priority: Normal

NCT ID: NCT00005714 Org: User:

Start: 08/31/90 End: 07/31/96 Due: 07/31/97

Hostility and Coronary Risk--Role of Weak Vagal Function

Phase: N/A Priority: Normal

NCT ID: NCT00005337 Org: User:

Start: 04/30/91 End: 03/31/95 Due: 03/31/96

Genetics of Airway Responsiveness and Lung Function

Phase: N/A Priority: Normal

NCT ID: NCT00005537 Org: User:

Start: 07/31/97 End: 06/30/02 Due: 06/30/03

The Role of Nitrite in Preconditioning Mediated Tolerance to Ischemic Stress

Phase: N/A Priority: Normal

NCT ID: NCT00250185 Org: User:

Start: 11/01/05 End: 06/09/07 Due: 06/09/08

Title	NCT ID	Organization	User	Status	Start Date	End Date	Reporting Due Date	Last Checked	User Role	Org Created
Effects of Worksite Wellness Interventions on Vascular Function, Insulin Sensitivity and High-Density Lipoprotein in Overweight or Obese Women	NCT00666172	National Heart, Lung, and Blood Institute (NHLBI)	user2@example.com	None	2008-04-08	2012-11-01	2013-11-01	-	-	2025-07-14
Vascular Effects of Endothelium-Derived Versus Hemoglobin-Transported Nitric Oxide in Healthy Subjects	NCT00001963	National Heart, Lung, and Blood Institute (NHLBI)	user2@example.com	None	1999-12-31	2000-10-31	2001-10-31	-	-	2025-07-14
Framingham Nutrition Studies	NCT00005513	National Heart, Lung, and Blood Institute (NHLBI)	user2@example.com	None	1998-09-30	2002-07-31	2003-07-31	-	-	2025-07-14
Atherosclerosis and Omega-3 Fatty Acids in Alaskan Natives	NCT00005236	National Heart, Lung, and Blood Institute (NHLBI)	user2@example.com	None	1988-12-31	1994-11-30	1995-11-30	-	-	2025-07-14
Biomarkers for Cardiovascular Disease	NCT00109018	National Heart, Lung, and Blood Institute (NHLBI)	user2@example.com	None	2005-04-19	2009-04-15	2010-04-15	-	-	2025-07-14
Aplastic Anemia Epidemiology: Incidence and Case-control	NCT00005682	National Heart, Lung, and Blood Institute (NHLBI)	user2@example.com	None	1988-09-30	1994-08-31	1995-08-31	-	-	2025-07-14
Coronary Heart Disease Incidence, Mortality, and Risk Factor Relationships	NCT00005148	National Heart, Lung, and Blood Institute (NHLBI)	user2@example.com	None	1979-09-30	1991-08-31	1992-08-31	-	-	2025-07-14
Blood Pressure Tracking--Childhood to Young Adulthood	NCT00005421	National Heart, Lung, and Blood Institute (NHLBI)	user2@example.com	None	1992-09-30	1995-03-31	1996-03-31	-	-	2025-07-14
Hemoglobin and Iron Recovery Study	NCT01555060	National Heart, Lung, and Blood Institute (NHLBI)	user2@example.com	None	2012-03-31	2013-06-30	2014-06-30	-	-	2025-07-14
Rituxan/BEAM vs Bexxar/BEAM in Autologous Hematopoietic Stem Cell Transplant for Non-Hodgkin's Lymphoma (BMTCTN0401)	NCT00329030	National Heart, Lung, and Blood Institute (NHLBI)	user2@example.com	None	2005-12-31	2013-08-31	2014-08-31	-	-	2025-07-14
Pilot Study of Strength Testing in Overweight Women With or Without Insulin Resistance	NCT01862757	National Heart, Lung, and Blood Institute (NHLBI)	user2@example.com	None	2013-05-06	2015-03-13	2016-03-13	-	-	2025-07-14
Neighborhood Environments and Cardiovascular Disease	NCT00005505	National Heart, Lung, and Blood Institute (NHLBI)	user2@example.com	None	1997-12-31	2002-11-30	2003-11-30	-	-	2025-07-14
Genetic Basis of Immunodeficiency	NCT00055172	National Heart, Lung, and Blood Institute (NHLBI)	user2@example.com	None	2004-04-05	-	-	-	-	2025-07-14
Magnetic Resonance Imaging to Detect Blood Vessel Inflammation in Patients Undergoing Peripheral Balloon Angioplasty	NCT00004549	National Heart, Lung, and Blood Institute (NHLBI)	user2@example.com	None	2000-01-31	2002-01-31	2003-01-31	-	-	2025-07-14
Effects of Rosuvastatin on the Immune System in Healthy Volunteers With Normal Cholesterol	NCT01200836	National Heart, Lung, and Blood Institute (NHLBI)	user2@example.com	None	2010-07-01	2018-10-04	2019-10-04	-	-	2025-07-14
Phosphodiesterase Type-5 Inhibitor Therapy in Sickle Cell People With Pulmonary Hypertension	NCT03572036	National Heart, Lung, and Blood Institute (NHLBI)	user2@example.com	None	2018-06-20	2021-04-16	2022-04-16	-	-	2025-07-14
Weight Set-Point and HDL Concentration in Runners	NCT00005342	National Heart, Lung, and Blood Institute (NHLBI)	user2@example.com	None	1993-05-31	1997-04-30	1998-04-30	-	-	2025-07-14
Complement Inhibition Using Eculizumab to Overcome Platelet Transfusion Refractoriness in Patients With Severe Thrombocytopenia	NCT02298933	National Heart, Lung, and Blood Institute (NHLBI)	user2@example.com	None	2014-11-21	2017-08-08	2018-08-08	-	-	2025-07-14
Specimen Collection for Individuals With Lung Disease Associated With Rheumatoid Arthritis	NCT00001884	National Heart, Lung, and Blood Institute (NHLBI)	user2@example.com	None	1999-03-21	2007-12-28	2008-12-28	-	-	2025-07-14
Lay-Led Smoking Cessation Approach for Southeast Asian Men	NCT00005720	National Heart, Lung, and Blood Institute (NHLBI)	user2@example.com	None	1990-09-30	1996-08-31	1997-08-31	-	-	2025-07-14
Treatment With Octreotide in Patients With Lymphangioleiomyomatosis	NCT00005906	National Heart, Lung, and Blood Institute (NHLBI)	user2@example.com	None	2000-06-30	-	-	-	-	2025-07-14
Development and Evaluation of Community Asthma Program	NCT00005714	National Heart, Lung, and Blood Institute (NHLBI)	user2@example.com	None	1990-08-31	1996-07-31	1997-07-31	-	-	2025-07-14
Hostility and Coronary Risk--Role of Weak Vagal Function	NCT00005337	National Heart, Lung, and Blood Institute (NHLBI)	user2@example.com	None	1991-04-30	1995-03-31	1996-03-31	-	-	2025-07-14
Genetics of Airway Responsiveness and Lung Function	NCT00005537	National Heart, Lung, and Blood Institute (NHLBI)	user2@example.com	None	1997-07-31	2002-06-30	2003-06-30	-	-	2025-07-14
The Role of Nitrite in Preconditioning Mediated Tolerance to Ischemic Stress	NCT00250185	National Heart, Lung, and Blood Institute (NHLBI)	user2@example.com	None	2005-11-01	2007-06-09	2008-06-09	-	-	2025-07-14

Compliance Rate

My Organizations' Clinical Trials

Appearance